DGAP-News
Biotest AG: Biotest takes over Cara Plasma s.r.o. with one plasma collection centre in the Czech Republic
DGAP-News: Biotest AG / Key word(s): Miscellaneous PRESS RELEASE |
Biotest takes over Cara Plasma s.r.o. with one plasma collection centre in the Czech Republic
- Long-term plasma supplier Cara Plasma was taken over by Biotest
- Biotest has now 16 plasma collection centres in Europe and
- 22 stations in the USA for the strategic safeguarding of plasma supply
Dreieich, 19 July 2017. Today, Biotest took over its long-time plasma supplier Cara Plasma s.r.o. and thus increased the number of plasma centres in Europe to 16.
With Cara Plasma Biotest purchased a station in the Czech capital Prague and will further increase the plasma self-sufficiency rate.
"The additional station in the Czech Republic gives us the opportunity to secure the supply for our production facilities with plasma. We are raising the good and trustworthy cooperation with our long-term partner and current supplier Cara Plasma to a new stage." stated Dr. Martin Reinecke, Head of Plasma Alliances and Protein Supply.
The collected plasma is processed exclusively at Biotest AG, Dreieich, Germany. Audits conducted regularly in the Czech Republic ensure that high legal and internal quality requirements are met.
Biotest's strategic goal is to increase the share of plasma from its own centres in the future. At the same time Biotest is striving for a balanced supply of plasma from Europe and the USA.
About human blood plasma
Human blood plasma is a raw material used to produce plasma derived products, which are used to treat various illnesses of the immune system, the blood system, as well as in emergency medicine.
Biotest ranks as one of the world's sixth largest plasma protein product manufacturing groups. Biotest is one of the world's six largest manufacturers of plasma protein products.